Results 141 to 150 of about 20,043 (161)

Efavirenz

Reactions Weekly, 2015
openaire   +1 more source

Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients

Journal of Antimicrobial Chemotherapy, 2017
Susan Swindells, Courtney Fletcher, Anthony Podany   +2 more
exaly  

Efavirenz

Reactions Weekly, 2016
openaire   +2 more sources

CYP2B6 (c.516G→T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV‐infected patients

British Journal of Clinical Pharmacology, 2009
Awewura Kwara
exaly  

Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms

European Journal of Pharmaceutical Sciences, 2017
Nadia Grilo, E C Monteiro, Jacinta Serpa   +2 more
exaly  

Efavirenz

Reactions Weekly, 2008
openaire   +1 more source

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

EBioMedicine, 2015
Christoph Wyen, Amalio Telenti, Andrew Badley   +2 more
exaly  

Efavirenz

Inpharma Weekly, 1999
openaire   +1 more source

Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial

Clinical Infectious Diseases, 2014
Sean Emery, Ploenchan Chetchotisakd, Saye Khoo   +2 more
exaly  

Induction of CYP3A4 by Efavirenz in Primary Human Hepatocytes: Comparison With Rifampin and Phenobarbital

Journal of Clinical Pharmacology, 2004
Pankaj Desai
exaly